Gene therapy applications of non-human lentiviral vectors by Munis, AM

A human surfactant B deficiency air-liquid interface cell culture model suitable for gene therapy applications by Munis, AM, Hyde, SC, Gill, DR

A tool with many applications: vesicular stomatitis virus in research and medicine by Munis, AM, Bentley, EM, Takeuchi, Y

Genome-wide integration site detection using Cas9 enriched amplification-free long-range sequencing by van Haasteren, J, Munis, AM, Gill, DR

Genomic diversity of SARS-CoV-2 in Oxford during United Kingdom’s first national lockdown by Munis, AM, Andersson, M, Mobbs, A, Hyde, SC, Gill, DR

RNA-Seq analysis of the human surfactant air-liquid interface culture reveals alveolar Type II cell-like transcriptome by Munis, AM, Wright, B, Jackson, F, Lockstone, H, Hyde, SC, Green, CM, Gill, DR

A high-throughput cell culture model of idiopathic pulmonary fibrosis (IPF) for gene therapy applications by Cerezuela, MP, Munis, AM, Du, Y, Chahrour, C, Lockstone, H, Broxholme, J, Wright, B, Hyde, SC, Gill, D

Lentivector producer cell lines with stably expressed vesiculovirus envelopes by Tijani, M, Munis, AM, Perry, C, Sanber, K, Ferraresso, M, Mukhopadhyay, T, Themis, M, Nisoli, I, Mattiuzzo, G, Collins, MK, Takeuchi, Y

Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus by Downes, DJ, Cross, AR, Hua, P, Roberts, N, Schwessinger, R, Cutler, AJ, Munis, AM, Brown, J, Mielczarek, O, de Andrea, CE, Melero, I, Gill, DR, Hyde, SC, Knight, JC, Todd, JA, Sansom, SN, Issa, F, Davies, JOJ, Hughes, JR